Skip to Main Content
TRC_PL _Site
Menu
    • Products
      • MY PRODUCTS
      • Pharmacist's Letter
      • RxSelect
      • OTHER PRODUCTS
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced

    Logged in as Idaho State University College of Pharmacy Create Username  Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty & Preceptor Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • Forum
    • Forum
    • Forum and Comments Policy
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  • March 1996
  • withdrawal syndrome when some patients stop taking SSRIs
  • using SSRIs for alcoholism
  • an ACE inhibitor such as enalapril (Vasotec) being used to prevent MIGRAINES
  • A new sulfonylurea called Amaryl (AM-a-ril, glimepiride)
  • using ANTIBIOTICS for asthma
  • novel peak flow meter on the market called AirWatch
  • new warnings for all OTC products containing phenylpropanolamine (PPA)
  • surprising new theory about chronic fatigue syndrome (CFS)
  • lamotrigine (Lamictal) for children
  • INHALED steroids for croup
  • new IV immune globulin called RespiGam
  • Naprelan, the first once-a-day version of naproxen sodium
  • big public awareness campaign to educate people about hepatitis
  • new OTC product called PMS Escape
  • acyclovir to suppress genital herpes
  • Watch for Covera-HS

Watch for Covera-HS

March 1996
  • Comments (0)
  • View Printable PDF

P.S. Watch for Covera-HS...a new ONCE-DAILY verapamil coming out this month from Searle. It's specifically designed for BEDTIME dosing...we'll fill you in on the details in the next issue.

Key References

FDC Reports 1996;58(4):T&G-5.

Previous Article
Comments (0)
Login to Comment
March 1996

Table of Contents

  • withdrawal syndrome when some patients stop taking SSRIs
  • using SSRIs for alcoholism
  • an ACE inhibitor such as enalapril (Vasotec) being used to prevent MIGRAINES
  • A new sulfonylurea called Amaryl (AM-a-ril, glimepiride)
  • using ANTIBIOTICS for asthma
  • novel peak flow meter on the market called AirWatch
  • new warnings for all OTC products containing phenylpropanolamine (PPA)
  • surprising new theory about chronic fatigue syndrome (CFS)
  • lamotrigine (Lamictal) for children
  • INHALED steroids for croup
  • new IV immune globulin called RespiGam
  • Naprelan, the first once-a-day version of naproxen sodium
  • big public awareness campaign to educate people about hepatitis
  • new OTC product called PMS Escape
  • acyclovir to suppress genital herpes
  • Watch for Covera-HS
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved